Evidence map›Paper›PMID 32397443›Full record

ReviewInternational journal of molecular sciences2020

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.

Anna Esposito, Daniele D'Alonzo, Maria De Fenza, Eliana De Gregorio, Anna Tamanini, Giuseppe Lippi, Maria Cristina Dechecchi, Annalisa Guaragna

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Frontiers in microbiology · 2026
    Article
  3. Article
  4. Ethyl (2IUCrData · 2024
    Article
  5. Assessing the Potential ofACS pharmacology & translational science · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Tuning the activity of iminosugars: novelJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  13. The Glucocorticoid PYED-1 Disrupts Mature Biofilms ofAntibiotics (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Editorial: Special Issue on "Therapeutic Approaches for Cystic Fibrosis".International journal of molecular sciences · 2020
    Article
  18. Antibiotics (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna EspositoDepartment of Chemical Sciences, University of Napoli Federico II, via Cintia, 80126 Napoli, Italy.
Daniele D'AlonzoDepartment of Chemical Sciences, University of Napoli Federico II, via Cintia, 80126 Napoli, Italy.
Maria De FenzaDepartment of Chemical Sciences, University of Napoli Federico II, via Cintia, 80126 Napoli, Italy.
Eliana De GregorioDepartment of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, via S. Pansini 5, 80131 Napoli, Italy.
Anna TamaniniLaboratory of Molecular Pathology-Department of Pathology and Diagnostics, University Hospital of Verona, 37126 Verona, Italy.
Giuseppe LippiDepartment of Neurosciences, Biomedicine and Movement, Section of Clinical Biochemistry, University of Verona, 37134 Verona, Italy.
Maria Cristina DechecchiDepartment of Neurosciences, Biomedicine and Movement, Section of Clinical Biochemistry, University of Verona, 37134 Verona, Italy.
Annalisa GuaragnaDepartment of Chemical Sciences, University of Napoli Federico II, via Cintia, 80126 Napoli, Italy.

Funding

Fondazione per la Ricerca sulla Fibrosi Cistica FFC grant #20/2019Fondazione per la Ricerca sulla Fibrosi Cistica FFC grant #23/2018
6 · The paper itself

Abstract

Iminosugars are sugar analogues endowed with a high pharmacological potential. The wide range of biological activities exhibited by these glycomimetics associated with their excellent drug profile make them attractive therapeutic candidates for several medical interventions. The ability of iminosugars to act as inhibitors or enhancers of carbohydrate-processing enzymes suggests their potential use as therapeutics for the treatment of cystic fibrosis (CF). Herein we review the most relevant advances in the field, paying attention to both the chemical synthesis of the iminosugars and their biological evaluations, resulting from in vitro and in vivo assays. Starting from the example of the marketed drug NBDNJ (

Indexed as

1-DeoxynojirimycinAnti-Inflammatory AgentsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGlycoside HydrolasesGlycosyltransferasesHeterocyclic Compounds, 1-RingHumansImino PyranosesInflammationMolecular StructureMutationSequence DeletionTartrates1-DeoxynojirimycinAnti-Inflammatory AgentsAT2101CFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorGlycoside HydrolasesGlycosyltransferasesHeterocyclic Compounds, 1-RingImino PyranosesmigalastatmiglitolmiglustatTartratesanti-inflammatory agentsCFTR correctorscystic fibrosiscystic fibrosis transmembrane conductance regulator (CFTR)glycomimeticsglycosidase inhibitorsiminosugarsmiglustat

Identifiers

PMID32397443
PMCPMC7247015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.